Navigation Links
Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics

the FDA, risks relating to the ability of Discovery Labs or Discovery Labs third party manufacturers and development partners to manufacture or provide Discovery Labs with adequate supplies of drug substances and expertise for completion of any of Discovery Labs clinical studies, risks related to the ability of Discovery Labs and its collaborators to develop, manufacture and successfully commercialize products that combine Discovery Labs drug products with innovative aerosolization technologies, risks relating to drug manufacturing by Discovery Labs, risks relating to the significant, time-consuming and costly research, development, pre-clinical studies, clinical testing and regulatory approval process for any products that Discovery Labs may develop independently or with Discovery Labs collaboration arrangements, risks relating to the development by other companies of competing therapies and/or technologies, risks relating to reimbursement and health care reform, and risks relating to securities, product liability and other litigation. Companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in advanced clinical trials, even after obtaining promising earlier trial results. Data obtained from tests are susceptible to varying interpretations, which may delay, limit or prevent regulatory approval. Those associated risks and others are further described in Discovery Labs filings with the Securities and Exchange Commission including the most recent reports on Forms 10-K, 10-Q and 8-K, and any amendments thereto.

-0- CONTACT: Discovery Laboratories, Inc. Investor Relations Lisa Caperelli 215-488-9413



'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric Academic Societies Annual Meeting
2. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
3. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
4. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
5. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
6. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
7. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
8. UCB Presents Long-Term CImzia Data in Crohns Disease
9. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
10. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
11. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
Post Your Comments:
(Date:7/24/2014)... 24, 2014  Uroplasty, Inc. (NASDAQ: UPI ... and markets innovative proprietary products to treat voiding ... 2015 first quarter ended June 30, 2014.  ... Neuromodulation System grew 19% to $4.1 million, as ... of the prior year.  Total revenue for the ...
(Date:7/24/2014)... 24, 2014 Omnicell, Inc. (NASDAQ: ... and supply management solutions and analytics software for ... 31, to discuss the Company,s Second Quarter 2014 ... 2014 earnings conference call and webcastWhen: , ... Lipps, chairman, president and chief executive officer ...
(Date:7/24/2014)... 24, 2014  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... of fiscal year 2014 financial results after the market ... call will follow on the same day at 4:30 ... be hosted by Dan Myers , President and ...
Breaking Medicine Technology:Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2Alimera Sciences To Release Second Quarter 2014 Results 2
... A new approach to unblocking heart arteries minimally invasively ... and less risk overall, particularly for obese patients, according ... Symposium on Endovascular Therapy (ISET). Every year, about one ... open their blocked arteries. New data suggests that beginning ...
... Excalibur, the international,investment house specialising in medical ... to deliver pioneering stem cell treatments if it ... , Professor Sir Christopher ... that ReNeuron plc has received approval from the ...
Cached Medicine Technology:Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries 2UK Must Maintain its Momentum in Stem Cell Expertise 2
(Date:7/24/2014)... Kathleen Doheny HealthDay Reporter ... of obese children often don,t view their kids as unhealthy ... according to a new study. The children of the ... clinic at the Hasbro Children,s Hospital in Providence, R.I. ... good," said study researcher Dr. Kyung Rhee, now an assistant ...
(Date:7/24/2014)... treatment of overweight and obese preschoolers works better when ... only the child is targeted, according to research published ... the University at Buffalo and Women and Children,s Hospital ... or obese and had one parent who participated in ... to body mass index (BMI) measurements, calculated based on ...
(Date:7/24/2014)... like a medical device or surgical implant is put ... to Northwestern University,s Guillermo Ameer, most of the time, ... function. , "You will always get an inflammatory response ... in Northwestern,s McCormick School of Engineering and Applied Science ... Medicine. "A problem with commonly used plastic materials, in ...
(Date:7/24/2014)... Horizon BCBSNJ’s second annual “Back to ... a rent-free week in a beautiful Lavallette shore house, ... miss your chance to win a week’s vacation at ... New Jersey residents, 25 or older.* Residents can enter ... . , “A family vacation at the Jersey ...
(Date:7/24/2014)... IA (PRWEB) July 24, 2014 Members of ... Michael Wolnerman, RPh, CCIM, Senior Associate of Sales at OutcomesMTM, ... Governor appointed him to the Board and that his peers ... “I want to provide the best I can for the ... I am uniquely positioned to provide a special insight to ...
Breaking Medicine News(10 mins):Health News:Parents of Obese Kids Often View Them as Healthy 2Health News:Parents of Obese Kids Often View Them as Healthy 3Health News:Overweight and obese preschoolers lose more weight when parent is also treated 2Health News:Overweight and obese preschoolers lose more weight when parent is also treated 3Health News:Antioxidant biomaterial promotes healing 2Health News:(Beach) Sands of Time Running out to Enter Horizon Blue Cross Blue Shield of New Jersey’s 2014 “Back to the Boardwalk” Sweepstakes 2Health News:Wolnerman Re-elected as Chairperson of Iowa State Board of Health 2
... the numbers of heart transplants are on the decline. This ... properly//. Hence the doctors at the Papworth Hospital in Cambridge ... for five hours after it was removed from the donor. ... transplant was Michael Burt, 58, a builder from Burnham Market, ...
... US –based research has given hopes that researchers will be ... in the ears of humans challenged by deafness//. ,These tiny ... is then translated by the brain into sound. Once ... in permanent hearing loss. , ,Approximately, one out of every ...
... studies by Canadian researchers show that the male ... that are not recognized and understood// many health ... researchers found that though both male and female ... anxieties and fears about their encounters with health ...
... standards officers have issued a warning to the public that ... prescription drugs through the Internet//. , , Drugs such as ... have often turned out to be fakes or ... partaking of drugs without a prescription can turn ...
... the 23rd June recalled almost around 20,000 chocolate bars ... fears// that those bars may contain traces of salmonella. ... that there were minute traces of salmonella, which though ... the scientific standards for any hazards. The spokesperson had ...
... ahead of Sunday's game, after research has shown that the ... football matches. The game with Ecuador is the first knockout match ... BUPA said: "When people's emotions run high stress levels can shoot ... that history does not repeat itself”. "If England gets ...
Cached Medicine News:Health News:Latest In the Heart Transplant Field 2Health News:Sexually Abused Males Found Struggling In heir relations with Healthcare Providers 2
... ANA and ENA assays can be ... for antinuclear antibodies, which are associated ... as Systemic lupus erythematosus (Lupus), Sjgren's ... systemic sclerosis, scleroderma, polymyositis, dermatomyositis, and ...
Anti-Tg and Anti-TPO are two major autoantibodies implicated in autoimmune related thyroiditis and aid in the differential diagnosis of Hashimoto's thyroiditis and Graves' disease....
... an automated, turbidimetric, whole- blood assay designed ... ability of activated platelets to bind to ... the VerifyNow IIb/IIIa assay device contains all ... analysis. Within the well is an activator ...
... first commercial product is the VerifyNow System, ... assay devices . The advantages of the ... use of a vacuum-type blood collection tube ... minutes. VerifyNow IIb/IIIa, the first assay developed ...
Medicine Products: